1. Home
  2. RCKT vs OI Comparison

RCKT vs OI Comparison

Compare RCKT & OI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • OI
  • Stock Information
  • Founded
  • RCKT 1999
  • OI 1903
  • Country
  • RCKT United States
  • OI United States
  • Employees
  • RCKT N/A
  • OI N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • OI Containers/Packaging
  • Sector
  • RCKT Health Care
  • OI Consumer Discretionary
  • Exchange
  • RCKT Nasdaq
  • OI Nasdaq
  • Market Cap
  • RCKT 384.1M
  • OI 1.9B
  • IPO Year
  • RCKT N/A
  • OI N/A
  • Fundamental
  • Price
  • RCKT $3.20
  • OI $13.22
  • Analyst Decision
  • RCKT Buy
  • OI Buy
  • Analyst Count
  • RCKT 13
  • OI 7
  • Target Price
  • RCKT $12.88
  • OI $16.29
  • AVG Volume (30 Days)
  • RCKT 2.6M
  • OI 1.8M
  • Earning Date
  • RCKT 11-03-2025
  • OI 11-04-2025
  • Dividend Yield
  • RCKT N/A
  • OI N/A
  • EPS Growth
  • RCKT N/A
  • OI N/A
  • EPS
  • RCKT N/A
  • OI N/A
  • Revenue
  • RCKT N/A
  • OI $6,455,000,000.00
  • Revenue This Year
  • RCKT N/A
  • OI $1.67
  • Revenue Next Year
  • RCKT $3,582.16
  • OI $1.04
  • P/E Ratio
  • RCKT N/A
  • OI N/A
  • Revenue Growth
  • RCKT N/A
  • OI N/A
  • 52 Week Low
  • RCKT $2.19
  • OI $9.23
  • 52 Week High
  • RCKT $18.17
  • OI $16.04
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 39.40
  • OI 61.62
  • Support Level
  • RCKT $3.19
  • OI $11.13
  • Resistance Level
  • RCKT $3.85
  • OI $13.87
  • Average True Range (ATR)
  • RCKT 0.22
  • OI 0.43
  • MACD
  • RCKT -0.10
  • OI 0.16
  • Stochastic Oscillator
  • RCKT 2.27
  • OI 76.82

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About OI O-I Glass Inc.

O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.

Share on Social Networks: